Mangoceuticals (MGRX) EBIT Margin (2023 - 2025)
Historic EBIT Margin for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to 8953.45%.
- Mangoceuticals' EBIT Margin fell 76352400.0% to 8953.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 4142.63%, marking a year-over-year decrease of 29688000.0%. This contributed to the annual value of 1294.42% for FY2024, which is 341400.0% down from last year.
- According to the latest figures from Q3 2025, Mangoceuticals' EBIT Margin is 8953.45%, which was down 76352400.0% from 3133.98% recorded in Q2 2025.
- In the past 5 years, Mangoceuticals' EBIT Margin ranged from a high of 733.99% in Q3 2023 and a low of 8953.45% during Q3 2025
- Moreover, its 3-year median value for EBIT Margin was 1594.02% (2024), whereas its average is 2529.39%.
- Its EBIT Margin has fluctuated over the past 5 years, first soared by 14349100bps in 2024, then plummeted by -76352400bps in 2025.
- Mangoceuticals' EBIT Margin (Quarter) stood at 1050.87% in 2023, then crashed by -52bps to 1594.02% in 2024, then tumbled by -462bps to 8953.45% in 2025.
- Its last three reported values are 8953.45% in Q3 2025, 3133.98% for Q2 2025, and 4440.0% during Q1 2025.